• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个有早发性帕金森病的汉族家庭携带 PARK2 基因的新型复合杂合突变。

Han Chinese family with early-onset Parkinson's disease carries novel compound heterozygous mutations in the PARK2 gene.

机构信息

Department of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.

Department of Endocrine and Metabolic Diseases, The First People's Hospital of Hefei, Anhui Medical University, Hefei, China.

出版信息

Brain Behav. 2019 Sep;9(9):e01372. doi: 10.1002/brb3.1372. Epub 2019 Aug 6.

DOI:10.1002/brb3.1372
PMID:31386307
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6749482/
Abstract

PURPOSE

To identify deletions, duplications, and point mutations in 55 previously reported genes associated with Parkinson's disease (PD) and certain genes associated with tremor, spinocerebellar ataxia, and dystonia in a Han Chinese pedigree with early-onset Parkinson's disease (EOPD).

PATIENTS AND METHODS

Clinical examinations and genomic analyses were performed on six subjects belonging to three generations of a Han Chinese family. Target region capture and high-throughput sequencing were used to screen these genes associated with PD, tremor, spinocerebellar ataxia, and dystonia. The multiplex ligation-dependent probe amplification (MLPA) method was applied to detect rearrangements in PARK2 exons. Direct Sanger sequencing of samples from all subjects further verified the detected abnormal PRKRA, SPTBN2, and ATXN2 gene fragments.

RESULTS

Two family members were diagnosed with PD based on the clinical manifestations, imaging analyses. PARK2 gene heterozygous deletion of exon 3 and heterozygous duplication of exon 6 were identified in them (II-3 and 4). A single heterozygous deletion of exon 3 in PARK2 was detected in II-5 and III-10. A single duplication of exon 6 in PARK2 was detected in I1. Both the heterozygous mutation c.2834G>A (p. R945H) in exon 16 and the heterozygous mutation c.1924 C>T (p. R642W) in exon 14 of the SPTBN2 gene were identified in II-3, II-4, and III-10. The heterozygous mutation c.2989 C>T (p. R997X) in exon 24 of the ATXN2 gene was detected in II-4 and II-5, and the heterozygous mutation c.170 C>A (p. S57Y) in exon 2 of the PRKRA gene was detected in II-3, II-4, and III-10. Other mutations in some genes associated with PD, tremor, spinocerebellar ataxia, and dystonia were not detected.

CONCLUSIONS

Novel compound heterozygous mutations were identified in a Han Chinese pedigree and might represent a cause of EOPD.

摘要

目的

在一个早发性帕金森病(EOPD)的汉族家系中,鉴定与帕金森病(PD)相关的 55 个先前报道的基因以及与震颤、脊髓小脑共济失调和肌张力障碍相关的某些基因中的缺失、重复和点突变。

方法

对属于三代汉族家系的 6 名个体进行临床检查和基因组分析。使用靶向区域捕获和高通量测序筛选与 PD、震颤、脊髓小脑共济失调和肌张力障碍相关的这些基因。应用多重连接依赖性探针扩增(MLPA)方法检测 PARK2 外显子的重排。对所有受试者的样本进行直接 Sanger 测序,进一步验证了所检测到的异常 PRKRA、SPTBN2 和 ATXN2 基因片段。

结果

根据临床表现和影像学分析,两名家族成员被诊断为 PD。在他们(II-3 和 4)中发现 PARK2 基因外显子 3 的杂合性缺失和外显子 6 的杂合性重复。PARK2 外显子 3 的单个杂合性缺失在 II-5 和 III-10 中被检测到。在 I1 中检测到 PARK2 外显子 6 的单个重复。在 II-3、II-4 和 III-10 中发现 SPTBN2 基因外显子 16 的杂合突变 c.2834G>A(p.R945H)和外显子 14 的杂合突变 c.1924 C>T(p.R642W)。在 II-4 和 II-5 中检测到 ATXN2 基因外显子 24 的杂合突变 c.2989 C>T(p.R997X),在 II-3、II-4 和 III-10 中检测到 PRKRA 基因外显子 2 的杂合突变 c.170 C>A(p.S57Y)。未检测到一些与 PD、震颤、脊髓小脑共济失调和肌张力障碍相关的基因的其他突变。

结论

在一个汉族家系中发现了新的复合杂合突变,可能是 EOPD 的病因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50bb/6749482/3268db9a68e2/BRB3-9-e01372-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50bb/6749482/15829df519ce/BRB3-9-e01372-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50bb/6749482/7f5c11fc74e3/BRB3-9-e01372-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50bb/6749482/3268db9a68e2/BRB3-9-e01372-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50bb/6749482/15829df519ce/BRB3-9-e01372-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50bb/6749482/7f5c11fc74e3/BRB3-9-e01372-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50bb/6749482/3268db9a68e2/BRB3-9-e01372-g003.jpg

相似文献

1
Han Chinese family with early-onset Parkinson's disease carries novel compound heterozygous mutations in the PARK2 gene.一个有早发性帕金森病的汉族家庭携带 PARK2 基因的新型复合杂合突变。
Brain Behav. 2019 Sep;9(9):e01372. doi: 10.1002/brb3.1372. Epub 2019 Aug 6.
2
Novel compound heterozygous mutations in the gene identified in a Chinese pedigree with early-onset Parkinson's disease.在中国一个早发性帕金森病家系中发现的 基因的新型复合杂合突变。
Brain Behav. 2017 Dec 19;8(1):e00901. doi: 10.1002/brb3.901. eCollection 2018 Jan.
3
Genetic study of a Chinese pedigree with early onset Parkinson's disease caused by novel compound heterozygous mutations in gene.一个由基因中新型复合杂合突变导致早发性帕金森病的中国家系的遗传学研究。
Ibrain. 2021 Jun 28;7(2):108-112. doi: 10.1002/j.2769-2795.2021.tb00072.x. eCollection 2021 Jun.
4
Analysis of Exon Dosage Using Multiplex Ligation-Dependent Probe Amplification in Chinese Patients with Early-Onset Parkinson's Disease.利用多重连接依赖探针扩增技术分析中国早发性帕金森病患者的外显子剂量
Eur Neurol. 2019;81(5-6):246-253. doi: 10.1159/000503421. Epub 2019 Oct 16.
5
[Genetic study of a Parkinson's disease pedigree caused by compound heterozygous mutations in PARK2 gene].
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2018 Dec 10;35(6):815-818. doi: 10.3760/cma.j.issn.1003-9406.2018.06.009.
6
Variable PARK2 Mutations Cause Early-Onset Parkinson's Disease in a Small Restricted Population.可变 PARK2 突变导致小部分特定人群的早发性帕金森病。
J Mol Neurosci. 2017 Oct;63(2):216-222. doi: 10.1007/s12031-017-0972-3. Epub 2017 Sep 15.
7
Mutation analysis of PARK2 in a Uyghur family with early-onset Parkinson's disease in Xinjiang, China.中国新疆一个早发性帕金森病维吾尔族家系中PARK2基因的突变分析
J Neurol Sci. 2014 Jul 15;342(1-2):21-4. doi: 10.1016/j.jns.2014.03.044. Epub 2014 Mar 31.
8
Whole exome sequencing identified a new compound heterozygous PRKN mutation in a Chinese family with early-onset Parkinson's disease.全外显子组测序在一个中国早发性帕金森病家系中发现了一个新的 PRKN 复合杂合突变。
Biosci Rep. 2020 May 29;40(5). doi: 10.1042/BSR20200534.
9
Breakpoint mapping of 13 large parkin deletions/duplications reveals an exon 4 deletion and an exon 7 duplication as founder mutations.13 个大 parkin 缺失/重复的断点作图揭示了一个exon4 缺失和一个exon7 重复作为主要突变。
Neurogenetics. 2011 Nov;12(4):263-71. doi: 10.1007/s10048-011-0302-9. Epub 2011 Oct 13.
10
Genetic mutations in early-onset Parkinson's disease Mexican patients: molecular testing implications.早发性帕金森病墨西哥患者的基因突变:分子检测的意义。
Am J Med Genet B Neuropsychiatr Genet. 2014 Apr;165B(3):235-44. doi: 10.1002/ajmg.b.32228. Epub 2014 Feb 23.

引用本文的文献

1
The genetic spectrum of a cohort of patients clinically diagnosed as Parkinson's disease in mainland China.中国大陆一组临床诊断为帕金森病患者的基因谱。
NPJ Parkinsons Dis. 2023 May 17;9(1):76. doi: 10.1038/s41531-023-00518-9.
2
Correlation between serum renin-angiotensin system (RAS) level and depression and anxiety symptoms in patients with Parkinson's disease.帕金森病患者血清肾素-血管紧张素系统(RAS)水平与抑郁和焦虑症状的相关性
Saudi J Biol Sci. 2021 Apr;28(4):2146-2154. doi: 10.1016/j.sjbs.2021.02.029. Epub 2021 Feb 17.
3
A Han Chinese Family With Early-Onset Parkinson's Disease Carrying Novel Frameshift Mutation and Compound Heterozygous Mutation of Appearing Incompatible With MDS Clinical Diagnostic Criteria.

本文引用的文献

1
Activation mechanisms of the E3 ubiquitin ligase parkin.E3泛素连接酶帕金的激活机制。
Biochem J. 2017 Aug 30;474(18):3075-3086. doi: 10.1042/BCJ20170476.
2
Genetics of Parkinson's disease.帕金森病的遗传学
Mol Cell Probes. 2016 Dec;30(6):386-396. doi: 10.1016/j.mcp.2016.11.001. Epub 2016 Nov 4.
3
Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson's disease and Alzheimer's disease.氧化应激:抗氧化剂在帕金森病和阿尔茨海默病中的主要发病机制和潜在治疗靶点。
一个携带新型移码突变和复合杂合突变的早发性帕金森病汉族家系,其表现不符合骨髓增生异常综合征的临床诊断标准。
Front Neurol. 2020 Oct 9;11:582323. doi: 10.3389/fneur.2020.582323. eCollection 2020.
4
Parkin is the most common causative gene in a cohort of mainland Chinese patients with sporadic early-onset Parkinson's disease.在中国内地散发早发性帕金森病患者队列中,Parkin 是最常见的致病基因。
Brain Behav. 2020 Sep;10(9):e01765. doi: 10.1002/brb3.1765. Epub 2020 Jul 16.
Prog Neurobiol. 2016 Dec;147:1-19. doi: 10.1016/j.pneurobio.2016.07.005. Epub 2016 Oct 18.
4
Structural and Functional Impact of Parkinson Disease-Associated Mutations in the E3 Ubiquitin Ligase Parkin.E3泛素连接酶Parkin中帕金森病相关突变的结构和功能影响
Hum Mutat. 2015 Aug;36(8):774-86. doi: 10.1002/humu.22808. Epub 2015 Jun 3.
5
ATXN2 polyQ intermediate repeats are a modifier of ALS survival.ATXN2 多聚谷氨酰胺中间重复序列是 ALS 生存的修饰子。
Neurology. 2015 Jan 20;84(3):251-8. doi: 10.1212/WNL.0000000000001159. Epub 2014 Dec 19.
6
Targeting the low-hanging fruit of neurodegeneration.针对神经退行性病变中易于解决的问题。
Neurology. 2014 Oct 14;83(16):1470-3. doi: 10.1212/WNL.0000000000000894.
7
Next-generation phenotyping using the parkin example: time to catch up with genetics.利用帕金森病示例进行下一代表型分析:是时候跟上遗传学的步伐了。
JAMA Neurol. 2013 Sep 1;70(9):1186-91. doi: 10.1001/jamaneurol.2013.488.
8
Parkinson disease: from pathology to molecular disease mechanisms.帕金森病:从病理学到分子疾病机制。
Free Radic Biol Med. 2013 Sep;62:132-144. doi: 10.1016/j.freeradbiomed.2013.01.018. Epub 2013 Feb 4.
9
Pseudo-heterozygous rearrangement mutation of parkin.假性杂合 parkin 重排突变。
Mov Disord. 2012 Apr;27(4):552-5. doi: 10.1002/mds.24906. Epub 2012 Feb 5.
10
What genetics tells us about the causes and mechanisms of Parkinson's disease.遗传学告诉我们帕金森病的病因和发病机制。
Physiol Rev. 2011 Oct;91(4):1161-218. doi: 10.1152/physrev.00022.2010.